Alluvi, previously BI 4744, presents a significant development in weight management therapy. This dual stimulator targeting both GLP-1 and GIP targets demonstrates impressive effectiveness in clinical trials, https://gatherbookmarks.com/story23170568/alluvi-a-in-depth-dive-into-the-medication-s-prospects